when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

ENOBY (DENOSUMAB-QBDE) — FDA approval

October 29, 2025$LBRX ENOBYupdated 5mo ago

community read0 votes

Sponsor: HIKMA PHARMACEUTICALS USA INC. Form: SOLUTION. Route: INJECTION

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 1

approvalENOBY (DENOSUMAB-QBDE) — FDA approvalSep 26, 2025 · 375d ago

same company · ±60 days · 6

recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Oct 22, 2025
recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Oct 8, 2025
recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Oct 8, 2025

🐶 often sniffed alongside

top 5

tagApproval8 co-mentions · 2 sources
companyHikma Pharmaceuticals Plc4 co-mentions · 2 sources
companyHikma Pharmaceuticals USA Inc4 co-mentions · 2 sources
drugdenosumab4 co-mentions · 2 sources
drugXgeva4 co-mentions · 2 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?